Skip to Content

        - Home 
        - Funding					Opportunities            - The NCI Grants Process              - The Grants									Process: The Lifecycle of a Grant 
          - Application and Forms              - Electronic Submission, Electronic									Research Administration (eRA)
            - Grant Application									Forms
            - Preparing Grant Applications
            - NIH Grant Review Process
            - NCI Research and									Funding: Questions and Answers
            - NCI Extramural Glossary 
          - NCI Sponsored Research							Initiatives              - Program Announcements (PA)
            - Request for Applications (RFA)
            - Requests for									Proposals (RFP - Solicitations)
            - Small Business Coordination									(SBIT/STTR)
            - Trans-NIH Initiatives (R01,									R21)
            - Trans-NIH Small Grants (R03) 
          - Policies and Guidelines              - 
–NCI and NIH Grant Submission and Review Policies

–Clinical Research/Human Subjects Policies and										Guidelines

–NIH Grant Policies
 
            - NCI Grant Activity Codes/Mechanisms & Descriptions 
          - Grants and Contracts              - NCI Grants and									Training
            - Building									a Diverse Workforce
            - NCI Other									Funding (Contracts)
            - NCI Office									of Grants Administration
            - Research Program									Contacts
            - E-mail NCI Grants Referral Office
            - Pancreatic									Cancer Research Network
            - Prostate Cancer Foundation 
          - Cancer							Research Training 
        - Advisory Boards            - President's Cancer Panel              - Charter
            - Members / Roster
            - Meeting Information (Agendas, Minutes, etc.) 
          - National Cancer							Advisory Board              - Charter
            - Members / Roster
            - Meeting Information (Agendas, Minutes,									etc.) 
          - Board of Scientific							Advisors              - Charter
            - Members / Roster
            - Meeting Information (Agendas, Minutes, etc.) 
          - Board							of Scientific Counselors              - Charter
            - Members / Roster 
          - Clinical Trials and							Translational Research Advisory Committee              - Charter
            - Members / Roster
            - Meeting Information (Agendas, Minutes,									etc.) 
          - NCI Council of Research Advocates              - Charter
            - Members / Roster
            - Meeting Information (Agendas, Minutes,									etc.) 
          - Frederick							National Laboratory							Advisory Committee              - Charter
            - Members / Roster
            - Meeting Information (Agendas, Minutes, etc.) 
          - NCI Initial Review Groups              - Charter
            - Funtion Statement 
          - Special Emphasis Panel              - Charter
            - Members / Roster 
          - Office of Federal Advisory Committee							Policy
          - Board							Presentations 
        - Grant					Policies            - 
NCI and NIH Grant Submission and Review Policies

Clinical Research/Human Subjects Policies and Guidelines

NIH Grant Policies
 
          - NCI Full Year Funding Policy for RPG Awards FY 2024
          - NCI Grant Activity Codes/Mechanisms & Descriptions 
        - Consumer Advocates            - NCI								Consumer Guide to Peer ReviewThe NCI Consumer								Guide to Peer Review has been prepared to serve first as an introduction and							orientation to the National Cancer Institute (NCI) and its Research Programs and second to							define your role as a consumer in the Peer Review of applications that support extramural							clinical/population-based research conducted by Cancer Centers, Cooperative Groups, Program							Projects, and projects submitted in response to Requests for Applications (RFAs) and Program							Announcements (PAs). 
          - Cancer								Dictionary for Peer ReviewCancer Dictionary								for Peer Review is deigned to provide concise definitions of technical terms							frequently used in applications for NCI-sponsored investigator-initiated research. The terms							include those commonly associated with the molecular biology of cancer, immunology, and							clinical oncology. These definitions, in association with the review process, will increase							your familiarity and understanding of the biology and clinical aspects of cancer. We hope							this will facilitate and make your participation in the Peer Review process more meaningful.						
          - Office of Advocacy Relations
          - NCI							Council of Research Advocates 
        - Awarded Research            - The Research							Portfolio Online Reporting							Tools 

Back to PCP Page
| 2024Developing and Retaining a Robust and Diverse Cancer Workforce: Challenges and									Opportunities Across the National Cancer									Program |
|-------------------------------------------------------------------------------------------------------------------------------------------------------|
| September 12-13VirtualMeeting									OverviewAgenda/ParticipantsMeeting									Link (September 12)Meeting									Link (September 13)            |
| 2023Reducing Cancer Care Inequities: Leveraging Technology to									Enhance Patient Navigation        |
|----------------------------------------------------------------------------------------------------------|
| October 17Hybrid - New Orleans, LouisianaMeeting									OverviewAgenda/ParticipantsMinutesMeeting Link | November 2-3VirtualMeeting									OverviewAgenda/ParticipantsMinutesMeeting Link (November 2)Meeting Link (November 3) | December 7Hybrid - Bethesda, MarylandMeeting									OverviewAgenda/ParticipantsMinutesMeeting Link |
| 2023President's									Cancer Panel Initial Assessment of the National Cancer Plan |
|--------------------------------------------------------------------------------------|
| September 7VirtualMeeting									OverviewAgenda/ParticipantsMinutes                |
| 2020-2022Closing Gaps in Cancer Screening: Connecting People,									Communities, and Systems to Improve Equity and Access |
|------------------------------------------------------------------------------------------------------------------------------|
| 2021***Improving Resilience and Equity in Cancer Screening: Innovation to Increase										Screening*** |
|-----------------------------------------------------------------------------------------------------------|
| February 11, 2021VirtualInformation									FlyerAgenda/ParticipantsMinutes                              |
| 2020***Improving Resilence and Equity in Cancer Screening: Lessons from COVID-19 and										Beyond*** |
|----------------------------------------------------------------------------------------------------------|
| October 26-28, 2020VirtualInformation FlyerAgenda/ParticipantsMinutes                                    | Novermber 2-4, 2020VirtualInformation FlyerAgenda/ParticipantsMinutes | November 9-10, 2020VirtualInformation									FlyerAgenda/ParticipantsMinutes | November 16-18, 2020VirtualInformation									FlyerAgenda/ParticipantsMinutes |
| 2018-2019Promoting Value, Affordability, and Innovation in Cancer									Drug									Treatment; HPV Vaccination for Cancer Prevention |
|-------------------------------------------------------------------------------------------------------------------------------------------|
| June 10, 2016New York, NYInformation FlyerAgenda/ParticipantsMinutesStatement | December 9, 2016Arlington, VAInformation FlyerAgenda/ParticipantsMinutesStatement | March 27, 2017Philadelphia, PAInformation FlyerAgenda/ParticipantsMinutesStatement |   |
|-------------------------------------------------------------------------------|-----------------------------------------------------------------------------------|------------------------------------------------------------------------------------|--------|

| 2014-2015Connected									Health: Improving Patients' Engagement and Activation for Cancer-Related									Outcomes |
|------------------------------------------------------------------------------------------------------------------------|
| December 11, 2014Cambridge, MAInformation FlyerAgenda/ParticipantsMinutesStatement                                     | March 26, 2015San Francisco, CAInformation FlyerAgenda/ParticipantsMinutesStatement | July 9, 2015Chicago, ILInformation FlyerAgenda/ParticipantsMinutesPresentationsStatement |   |

| Archive Meeting Information - 1973 to 2014 | Top |
|--------------------------------------------|-----|

|  President's Cancer Panel Twitter Feed |   NCI YouTube Series |   Subscribe to Cancer.gov RRS Feeds |   Options for Viewing Files |
|---------------------------------------------|---------------------------|------------------------------------------|----------------------------------|

Home |		About DEA |		Contact Us

Policies |		Accessibility |		FOIA |		Vulnerability Disclosure Policy

U.S.			Department of Health and Human Services  | 		National Institutes of			Health  | 		National Cancer			Institute  | 		USA.gov
NIH... Turning Discovery into Health